Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Financials | 7.68% |
| 3 | Healthcare | 6.5% |
| 4 | Industrials | 5.87% |
| 5 | Consumer Discretionary | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
Immunovant
IMVT
$7.92B
| $1.42M | ﹤0.01% |
88,114
-113,058
| -56% | -$1.83M |
|
4227
Marten Transport
MRTN
$1.2B
| $1.42M | ﹤0.01% |
133,114
+111,093
| +504% | +$1.35M |
|
4228
Idaho Strategic Resources
IDR
$456M
| $1.41M | ﹤0.01% |
41,864
+29,146
| +229% | +$688K |
|
4229
Surrozen
SRZN
$255M
| $1.41M | ﹤0.01% |
+109,769
| New | +$1.15M |
|
4230
Twin Disc
TWIN
$332M
| $1.41M | ﹤0.01% |
101,384
-44,298
| -30% | -$479K |
|
4231
CALL
Avis
CAR
$4.91B
| $1.41M | ﹤0.01% |
+8,800
| New | +$1.48M |
|
4232
Atea Pharmaceuticals
AVIR
$372M
| $1.41M | ﹤0.01% |
487,223
+312,733
| +179% | +$1.07M |
|
|
AVDL
4233
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.41M | ﹤0.01% |
92,400
+74,400
| +413% | +$968K |
|
4234
Sundial Growers
SNDL
$318M
| $1.41M | ﹤0.01% |
525,291
-1,888,267
| -78% | -$3.79M |
|
4235
Materion
MTRN
$4.47B
| $1.41M | ﹤0.01% |
11,641
-47,462
| -80% | -$4.98M |
|
4236
PUT
CRH
CRH
$65.1B
| $1.4M | ﹤0.01% |
11,700
+300
| +3% | +$31.7K |
|
4237
TripAdvisor
TRIP
$1.67B
| $1.4M | ﹤0.01% |
85,819
-244,695
| -74% | -$4.27M |
|
4238
PUT
SharkNinja
SN
$22.7B
| $1.39M | ﹤0.01% |
13,500
-1,100
| -8% | -$126K |
|
|
SUIG
4239
Sui Group Holdings
SUIG
$70.4M
| $1.39M | ﹤0.01% |
+360,369
| New | +$1.63M |
|
4240
Fulcrum Therapeutics
FULC
$280M
| $1.39M | ﹤0.01% |
150,867
+45,174
| +43% | +$327K |
|
|
ELVR
4241
Elevra Lithium Ltd
ELVR
$984M
| $1.39M | ﹤0.01% |
+57,772
| New | +$1.2M |
|
4242
PUT
Public Storage
PSA
$61.1B
| $1.39M | ﹤0.01% |
+4,800
| New | +$1.38M |
|
4243
Altimmune
ALT
$578M
| $1.39M | ﹤0.01% |
367,582
+289,288
| +369% | +$1.12M |
|
4244
Jakks Pacific
JAKK
$299M
| $1.39M | ﹤0.01% |
73,949
+47,826
| +183% | +$879K |
|
|
ABX
4245
Abacus Global Management
ABX
$1.02B
| $1.38M | ﹤0.01% |
241,175
-857,768
| -78% | -$5.09M |
|
4246
Full House Resorts
FLL
$83.4M
| $1.38M | ﹤0.01% |
429,562
-321,260
| -43% | -$1.26M |
|
4247
CALL
New York Times
NYT
$12.2B
| $1.38M | ﹤0.01% |
+24,000
| New | +$1.37M |
|
4248
CALL
Blue Owl Capital
OWL
$7.62B
| $1.38M | ﹤0.01% |
81,300
+46,100
| +131% | +$877K |
|
4249
TFI International
TFII
$11.1B
| $1.37M | ﹤0.01% |
15,610
-232,672
| -94% | -$21.3M |
|
4250
Park Aerospace
PKE
$770M
| $1.37M | ﹤0.01% |
+67,416
| New | +$1.22M |
|
Similar funds
Millennium Management's Q3 2025 Portfolio in Review
As of Q3 2025, Millennium Management held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Millennium Management added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Millennium Management's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Millennium Management fully exited Hess in Q3 2025, selling an estimated $478M.
- Millennium Management's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Millennium Management opened 800 new positions and closed 633 in Q3 2025.
- Millennium Management's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.